{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:13:37Z","timestamp":1768778017107,"version":"3.49.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:00:00Z","timestamp":1384992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081400","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T22:29:59Z","timestamp":1385072999000},"page":"e81400","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["NT-proBNP Best Predictor of Cardiovascular Events and Cardiovascular Mortality in Secondary Prevention in Very Old Age: The Leiden 85-Plus Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Petra G.","family":"van Peet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne M.","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton J. M.","family":"de Craen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobijn","family":"Gussekloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"de Ruijter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics--2011 update: a report from the American Heart Association","volume":"123","author":"VL Roger","year":"2011","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.297.11.1253","article-title":"The international pandemic of chronic cardiovascular disease","volume":"297","author":"MM McDermott","year":"2007","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/hrt.2007.140905","article-title":"Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?","volume":"95","author":"AJ Kerr","year":"2009","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"PG Steg","year":"2007","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/eurheartj\/ehp099","article-title":"Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes","volume":"30","author":"DL Bhatt","year":"2009","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.STR.0000221212.36860.c9","article-title":"Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial","volume":"37","author":"H Arima","year":"2006","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/01.STR.0000190118.02275.33","article-title":"Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis","volume":"36","author":"E Touze","year":"2005","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.amjopharm.2011.04.002","article-title":"Secondary prevention of stroke in the elderly: a review of the evidence","volume":"9","author":"A Alhusban","year":"2011","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/STROKEAHA.110.580209","article-title":"Ischemic stroke and secondary prevention in clinical practice: a cohort study of 14,529 patients in the Swedish Stroke Register","volume":"41","author":"S Asberg","year":"2010","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCULATIONAHA.106.654756","article-title":"Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE)","volume":"115","author":"P Deedwania","year":"2007","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"J Shepherd","year":"2002","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/eurheartj\/ehr410","article-title":"Temporal trends of the gaps in post-myocardial infarction secondary prevention strategies of co-morbid and elderly populations vs. younger counterparts: an analysis of three successive cohorts between 2003 and 2008","volume":"33","author":"A Macchia","year":"2012","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3399\/bjgp10X482103","article-title":"Time trends in preventive drug treatment after myocardial infarction in older patients","volume":"60","author":"W de Ruijter","year":"2010","journal-title":"Br J Gen Pract"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/j.1532-5415.2012.04165.x","article-title":"Effect of Exposure to Evidence-Based Pharmacotherapy on Outcomes After Acute Myocardial Infarction in Older Adults","volume":"60","author":"IH Zuckerman","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"S Subherwal","year":"2012","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S0002","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to Drugs That Prevent Cardiovascular Disease: Meta-analysis on 376,162 Patients","volume":"125","author":"SH Naderi","year":"2012","journal-title":"Am J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"DL Bhatt","year":"2006","journal-title":"JAMA"},{"key":"ref18","first-page":"325","article-title":"PROCAM-, FRAMINGHAM-, S","volume":"39","author":"H Uthoff","year":"2010","journal-title":"VASA"},{"key":"ref19","article-title":"Prognostic value of cardiovascular disease status: the Leiden 85-plus study. Age (Dordr ) . 10.1007\/s11357-012-9443-5 [doi]","author":"PG van Peet","year":"2012"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/heartjnl-2013-303640","article-title":"Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score","volume":"99","author":"JA Dorresteijn","year":"2013","journal-title":"Heart"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"O Melander","year":"2009","journal-title":"JAMA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-156-6-201203200-00006","article-title":"Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study","volume":"156","author":"M Kavousi","year":"2012","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jacc.2011.02.041","article-title":"N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease","volume":"58","author":"SG Wannamethee","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.109.901413","article-title":"Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project","volume":"121","author":"S Blankenberg","year":"2010","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4065\/83.11.1203","article-title":"Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis","volume":"83","author":"LL Humphrey","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"K Bibbins-Domingo","year":"2007","journal-title":"JAMA"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2007.06.030","article-title":"Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study","volume":"121","author":"MG Shlipak","year":"2008","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study","volume":"114","author":"S Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S0167","DOI":"10.1016\/j.ijcard.2011.06.066","article-title":"Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases","volume":"157","author":"A Battistoni","year":"2012","journal-title":"Int J Cardiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.106.643114","article-title":"C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)","volume":"115","author":"N Sattar","year":"2007","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pmed.1000016","article-title":"Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis","volume":"6","author":"I Ford","year":"2009","journal-title":"PLoS Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(02)00505-X","article-title":"A high response is not essential to prevent selection bias: results from the Leiden 85-plus study","volume":"55","author":"AB van der Wiel","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-0736(96)80016-1","article-title":"Automated serial ECG comparison based on the Minnesota code","volume":"29","author":"PW Macfarlane","year":"1996","journal-title":"J Electrocardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ndt\/gfq661","article-title":"The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method","volume":"26","author":"M Verduijn","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1515\/CCLM.2010.340","article-title":"Statistical methods for assessment of added usefulness of new biomarkers","volume":"48","author":"MJ Pencina","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","article-title":"Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers","volume":"30","author":"MJ Pencina","year":"2011","journal-title":"Stat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"MJ Pencina","year":"2008","journal-title":"Stat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kws207","article-title":"Interpreting incremental value of markers added to risk prediction models","volume":"176","author":"MJ Pencina","year":"2012","journal-title":"Am J Epidemiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/sim.4780091109","article-title":"Predictive value of statistical models","volume":"9","author":"JC Van Houwelingen","year":"1990","journal-title":"Stat Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1536\/ihj.53.85","article-title":"Multimarker approach for the prediction of cardiovascular events in patients with mild to moderate coronary artery lesions. A 3-year follow-up study","volume":"53","author":"M Zhang","year":"2012","journal-title":"Int Heart J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"a3083","DOI":"10.1136\/bmj.a3083","article-title":"Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study","volume":"338","author":"W de Ruijter","year":"2009","journal-title":"BMJ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.CIR.102.11.1227","article-title":"Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease","volume":"102","author":"JL Anderson","year":"2000","journal-title":"Circulation"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1532-5415.2009.02218.x","article-title":"Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians","volume":"57","author":"B Vaes","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.109.884866","article-title":"B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies","volume":"120","author":"E Di Angelantonio","year":"2009","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa0707064","article-title":"Use of multiple biomarkers to improve the prediction of death from cardiovascular causes","volume":"358","author":"B Zethelius","year":"2008","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.110.989145","article-title":"Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the framingham offspring study","volume":"125","author":"A Pikula","year":"2012","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"C Kistorp","year":"2005","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.ATV.20.4.1057","article-title":"C-Reactive Protein, Cardiovascular Risk Factors, and Mortality in a Prospective Study in the Elderly","volume":"20","author":"TE Strandberg","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.amjcard.2009.02.029","article-title":"Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure","volume":"103","author":"S Manzano-Fernandez","year":"2009","journal-title":"Am J Cardiol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:20:35Z","timestamp":1540246835000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081400"}},"subtitle":[],"editor":[{"given":"Utpal","family":"Sen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,21]]},"references-count":49,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081400","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,21]]}}}